Suppr超能文献

两种治疗干预措施对脑瘫患儿慢性便秘治疗效果的比较:一项随机临床试验

Comparison of the Effect of Two Therapeutic Interventions for the Treatment of Chronic Constipation in Children With Cerebral Palsy: A Randomized Clinical Trial.

作者信息

Yousefi-Fatmesari Gholamreza, Chegene Lorestani Roya, Rostamian Mosayeb, Khodamoradi Sepideh, Sedighi Mostafa, Daryoushi Hooman, Norouzi Masoud, Hoseini Jamal, Ghadiri Keyghobad

机构信息

Department of Pediatrics, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Infectious Diseases Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

出版信息

Glob Pediatr Health. 2024 Sep 12;11:2333794X241274287. doi: 10.1177/2333794X241274287. eCollection 2024.

Abstract

. Constipation is one of the most common gastrointestinal symptoms in children with neurological disorders. This study was performed to compare the therapeutic effect of polyethylene glycol (PEG) plus domperidone with PEG plus placebo in the treatment of chronic constipation in children with cerebral palsy. . In this a double-blind clinical trial study was done on the children with cerebral palsy who had chronic constipation and was referred to Mohammad Kermanshahi hospital of Kermanshah city in the west of Iran. The participants were randomly divided into 2 groups with 2 therapies of PEG combined with domperidone (case group, n = 21) and PEG with placebo (control group, n = 21). The information was extracted from patients based on the checklist before and after treatment and the response to treatment in the 2 groups were determined and compared. The data were analyzed by T-test or Mann-Whitney U test to compare quantitative variables and Chi-square and Fisher's exact tests for comparing qualitative variables. . In both case and control groups, all Rome IV criteria for a diagnosis of chronic constipation except incontinence were significantly reduced after treatment. However, the successful response rate in the case group (PEG + domperidone) was 90.5%, while this rate was 61.9% in the control group. . Based on the results of the present study, it seems that PEG plus domperidone had a positive effect on the treatment of children with cerebral palsy and chronic constipation.

摘要

便秘是神经功能障碍患儿最常见的胃肠道症状之一。本研究旨在比较聚乙二醇(PEG)联合多潘立酮与PEG联合安慰剂治疗脑瘫患儿慢性便秘的疗效。在伊朗西部克尔曼沙阿市的穆罕默德·克尔曼沙希医院,对患有慢性便秘的脑瘫患儿进行了一项双盲临床试验研究。参与者被随机分为两组,分别接受PEG联合多潘立酮治疗(病例组,n = 21)和PEG联合安慰剂治疗(对照组,n = 21)。根据治疗前后的检查表从患者中提取信息,并确定和比较两组的治疗反应。采用T检验或曼-惠特尼U检验分析定量变量,采用卡方检验和费舍尔精确检验比较定性变量。在病例组和对照组中,除大便失禁外,所有罗马IV标准诊断的慢性便秘在治疗后均显著降低。然而,病例组(PEG + 多潘立酮)的成功反应率为90.5%,而对照组的这一比率为61.9%。根据本研究结果,PEG联合多潘立酮似乎对脑瘫合并慢性便秘患儿的治疗有积极作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc8f/11402094/ce4197d1af06/10.1177_2333794X241274287-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验